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Epigenetic chromatin marks restrict the ability
of differentiated cells to change gene expres-
sion programs in response to environmental
cues and to transdifferentiate. Polycomb group
(PcG) proteins mediate gene silencing and
repress transdifferentiation in a manner depen-
dent on histone H3 lysine 27 trimethylation
(H3K27me3). However, macrophages migrated
into inflamed tissues can transdifferentiate,
but it is unknown whether inflammation alters
PcG-dependent silencing. Here we show that
the JmjC-domain protein Jmjd3 is a H3K27me
demethylase expressed in macrophages in
response to bacterial products and inflamma-
tory cytokines. Jmjd3 binds PcG target genes
and regulates their H3K27me3 levels and
transcriptional activity. The discovery of an
inducible enzyme that erases a histone mark
controlling differentiation and cell identity pro-
vides a link between inflammation and reprog-
ramming of the epigenome, which could be
the basis for macrophage plasticity and might
explain the differentiation abnormalities in
chronic inflammation.
INTRODUCTION
Epigenetic mechanisms enforcing accessibility and usage
of the genetic material are the foundation of cell differenti-
ation. Epigenetic control is largely operated via covalent
modifications of histones and DNA, which are linked to
effector mechanisms by proteins bearing recognition do-
mains specific for modified residues (Jenuwein and Allis,
2001; Kouzarides, 2007).
In both Drosophila and mammals, histone H3 lysine 27
trimethylation (H3K27me3) brings about silencing of de-
velopmental genes, which is inheritable across cell gener-Cell 13ations (Lund and van Lohuizen, 2004). H3K27me3 is cata-
lyzed by a single SET-domain-containing enzyme, Ezh2,
which associates with Suz12, Eed, and RbAp48 to form
the Polycomb-repressive complex 2 (PRC2). H3K27me3
is recognized by the chromodomain of Polycomb (Pc) in
Drosophila, or of Polycomb orthologs in mammalian cells,
which are themselves part of multimolecular complexes
collectively known as PRC1 (Lund and van Lohuizen,
2004).
Genome-wide mapping of H3K27me3 and PcG pro-
teins in mammalian cells has shown co-occupancy of
a large set of genes whose products control cell fate
and embryonic development, including developmental
transcription factors (e.g., the homeotic Hox genes) and
cell-surface or extracellular proteins involved in cell fate
regulation and patterning (e.g., Wnt proteins and mem-
bers of the TGF-b superfamily)(Boyer et al., 2006; Bracken
et al., 2006; Lee et al., 2006).
PcG proteins are broadly expressed. However, their
levels can be modulated by environmental inputs, thus
linking extracellular cues to reprogramming of the epige-
nome. For instance, expression of the PRC1 component
Bmi1 in the cerebellum is controlled by the morphogen
sonic hedgehog (Leung et al., 2004). The most striking
example of the impact of extrinsic signals on Polycomb
function and cell differentiation is provided by imaginal
discs in Drosophila. Imaginal discs are larval clusters of
cells that generate the external cuticle and appendages
like legs and wings. When removed from larvae, frag-
mented and cultured in vitro, imaginal discs proliferate
and regenerate the corresponding body part. However,
in a few cases the disc can switch identity and generate
an alternative body part, a phenomenon known as trans-
determination (Hadorn, 1968): the frequency of transde-
termination events is greatly enhanced in PcGmutant flies
(Lee et al., 2005), indicating that PcG proteins limit
chromatin plasticity and epigenome reprogramming in
regenerating tissues.
The link between damage, regeneration, and repro-
gramming of the epigenome is strengthened by additional
experimental models. For instance, tail regeneration in
axolotls depends on transdifferentiation of neural cells0, 1083–1094, September 21, 2007 ª2007 Elsevier Inc. 1083
into cartilage and muscle (Echeverri and Tanaka, 2002),
and replacement of destroyed sensory hair cells of the
inner ear in the mouse relies on transdifferentiation of
epithelial support cells (White et al., 2006). Macrophages
and their progenitors also show some degree of plasticity
when exposed to inflammatory stimuli. After corneal
transplants in the mouse, macrophages infiltrate the in-
flamed cornea and transdifferentiate into lymphoendothe-
lial cells, thus generating a new system of lymphatic
vessels within the avascular cornea (Maruyama et al.,
2005). Similarly, de novo lymphoangiogenesis in rejected
and inflamed kidney transplants is due to recipient-
derived myeloid cells (Kerjaschki et al., 2006). Finally,
hematopoietic stem cells and progenitors bear receptors
for microbial components, whose triggering stimulates
survival, promotes macrophage differentiation, and
causes lymphoid progenitors to transdifferentiate into
dendritic cells (Nagai et al., 2006).
We previously reported that histone H3 lysine 9 methyl-
ation (H3K9me) is erased from the promoters of some
slowly activated inflammatory genes upon activation
(Saccani and Natoli, 2002), and we hypothesized the
requirement for a H3K9 demethylase in their activation.
However, no enzyme capable of demethylating histones
was known at that time. This scenario changed with the
identification of an enzyme capable of turning over meth-
ylated histone residues by deiminating mono-methylargi-
nine (PADI4) (Cuthbert et al., 2004), which was followed
by the discovery of the first true histone demethylase
(HDM), LSD1 (Shi et al., 2004; Metzger et al., 2005).
More recently, proteins containing the Jumonji C (JmjC)
domain were demonstrated to catalyze site-specific de-
methylation of mono-, di-, and trimethylated histones
(Tsukada et al., 2006; Klose et al., 2006). The JmjC domain
is a variant of the ‘‘2-His-1-carboxylate facial triad,’’
a structural motif in which a nonheme iron center is primed
for attack bymolecular oxygen upon binding of an a-oxoa-
cid cofactor (usually a-ketoglutarate) (Koehntop et al.,
2005). This generates a highly reactive oxidizing interme-
diate that catalyzes substrate oxidation. JmjC domain
proteins demethylate histones through a mechanism
involving hydroxylation of themethyl groups and their sub-
sequent release as formaldehyde (Tsukada et al., 2006).
About 30 proteins with a JmjC domain are annotated in
the mouse and human genomes (Klose et al., 2006),
although some of them are unlikely to be involved in his-
tone demethylation due either to their cytoplasmic locali-
zation or to aminoacidic substitutions in the iron- and/or
cofactor-binding sites.
With the initial aim of identifying an inducible H3K9
demethylase involved in inflammatory gene control (Sac-
cani and Natoli, 2002), we profiled the expression of
JmjC domain proteins in lipopolysaccharide (LPS)-stimu-
lated macrophages. We found that Jmjd3, an active hy-
droxylase with no described function, is quickly and
strongly induced in macrophages exposed to bacterial
products and inflammatory cytokines. Jmjd3 induction
depends on direct binding of the transcription factor1084 Cell 130, 1083–1094, September 21, 2007 ª2007 Elsevier INF-kB to a cluster of three kB sites in the Jmjd3 gene pro-
moter. Contrary to our initial expectations, Jmjd3 does not
demethylate H3K9. Instead, it is an efficient H3K27me3
demethylase that binds PcG target genes and regulates
their H3K27me3 levels and transcriptional activity.
RESULTS
Induction of Jmjd3 by Inflammatory Stimuli
in Macrophages
We first measured the effects of bacterial products and
inflammatory cytokines on the expression of JmjC domain
proteins in mouse macrophages. Quantitative PCR (Q-
PCR) analysis was carried out on cDNAs obtained from
Raw264.7 cells stimulated with LPS, a Toll-like receptor
4 (TLR4) agonist (Janeway and Medzhitov, 2002). Among
the about 30 JmjC genes annotated in themouse genome,
only 1, Jmjd3, was strongly induced by LPS stimulation
(Figures 1A and 1B). The closely related Utx and Uty
showed constant and comparatively low levels of expres-
sion. Jmjd3 mRNA upregulation occurred rapidly and
peaked between 1 and 2 hr after stimulation (Figure 1C).
Similar results were obtained in J774.1 macrophage cells
and in primary bone marrow-derived macrophages
(Figure 1D), while Jmjd3 expression was unaffected by
inflammatory stimuli in the nonmacrophage cells tested
(Figure 1E). Other TLR agonists, namely CpG containing
DNA sequences (TLR9) and zymosan particles (TLR2),
similarly induced Jmjd3 expression, while the cytokine
tumor necrosis factor alpha (TNFa) was much less effec-
tive (Figure 1F). Jmjd3 induction by TLR agonists in
primary macrophages required MyD88, an adaptor mole-
cule essential for signal transduction by TLRs (Figure 1G).
To analyze Jmjd3 expression at the protein level, we
raised a polyclonal antibody that efficiently recognizes
the endogenous protein. Consistent with the mRNA data,
Jmjd3 was expressed at low basal levels, and it was
strongly upregulated after LPS stimulation (Figure 1H).
Direct Regulation of Jmjd3 by NF-kB
NF-kB is a family of transcription factors required for the
induction of the most important classes of inflammatory
genes (Hayden et al., 2006).To determine the dependence
of Jmjd3 induction on NF-kB, we infected J774.1 macro-
phages with a recombinant adenovirus expressing a HA-
tagged IkBa ‘‘super repressor’’ (IkBa-SR) (Jobin et al.,
1998). In unstimulated cells IkBa binds NF-kB dimers
and prevents their nuclear accumulation. Upon activation
by inflammatory stimuli, the IkB kinase complex (Ikk)
phosphorylates IkBa at two N-terminal serines, thus
promoting its polyubiquitination and degradation and the
nuclear entry of the freed NF-kB dimers (Karin and Ben-
Neriah, 2000). Resynthesis of IkBa requires NF-kB binding
to the IkBa gene promoter and occurs quickly after NF-kB
activation. The IkBa super repressor contains Ser > Ala
mutations in the two Ikk phosphorylation sites. Therefore,
it does not undergo phosphorylation and degradation
and efficiently sequesters most NF-kB species in thenc.
Figure 1. Induction of Jmjd3 by Inflammatory Stimuli in Mouse Macrophages
(A and B) Expression of JmjC-domain proteins in LPS-stimulated Raw264.7 macrophages. Data are expressed as F.C. (fold change) (A) or as mRNA
levels relative to TBP (B). Means ± standard error are shown. Raw264.7 macrophages are male cells and express Uty.
(C) Kinetics of Jmjd3 mRNA upregulation in Raw264.7.
(D) Jmjd3 induction in primary bone marrow-derived macrophages and in cell lines after LPS stimulation.
(E) Jmjd3 mRNA levels in LPS stimulated MCF10 and 3T3 fibroblasts.
(F) Effect of TLR agonists and TNFa on Jmjd3 mRNA levels in mouse macrophages.
(G) MyD88 requirement for LPS-induced Jmjd3 upregulation.
(H) Jmjd3 was detected in untreated and LPS-treated Raw264.7 macrophages using an affinity-purified rabbit polyclonal antibody. Vinculin is shown
as a loading control.cytoplasm, as indicated by the lack of resynthesis of
endogenous IkBa 2 hr poststimulation (Figure 2A, upper
panel). Jmjd3 induction by LPS was strongly inhibited
by IkBa-SR, thus indicating that NF-kB was required for
its induction (Figure 2A). To obtain definitive genetic evi-
dence for the requirement of NF-kB in Jmjd3 induction,
we prepared macrophages from knockin mice in which
the Ikkg gene (encoding for an essential component of the
Ikk complex) is flanked by loxP sites and deleted upon Cre
recombinase-mediated excision (Luedde et al., 2007).
Macrophages were differentiated and treated with the
cell-permeant Tat-Cre fusion protein (Peitz et al., 2002)
2 days before LPS stimulation. Induction of the Jmjd3
mRNA was strongly impaired in Tat-Cre-treated cells,Cellthus confirming the requirement for NF-kB in the activa-
tion of Jmjd3 (Figure 2B).
To determine if NF-kB controls Jmjd3 induction directly,
we first aligned the mouse and human Jmjd3 genes to
identify stretches of conserved sequences containing
NF-kB-binding sites (kB sites)(Natoli et al., 2005). While
we could not identify any kB site in the 3000 bp upstream
of the annotated transcription start site (Figure 2C), we
found two regions in the annotated first intron (between
two noncoding exons) and one region in the 30 UTR, which
contain kB sites with a 100% conservation between the
mouse and the human genome. We next used chromatin
immunoprecipitation (ChIP) with an antibody directed
against the NF-kB subunit p65/RelA to measure NF-kB130, 1083–1094, September 21, 2007 ª2007 Elsevier Inc. 1085
Figure 2. Regulation of Jmjd3 Expression by NF-kB
(A) Expression of HA-tagged IkBa-SR in J774 cells blocks Jmjd3 mRNA induction by LPS (lower panel). IkBa-SR blocks resynthesis of endogenous
IkBa (anti-IkBa western blot).
(B) Jmjd3 induction in Ikkg-deficient macrophages. Macrophages from floxed Ikkgmice were treated with Tat-Cre as indicated and LPS stimulated
2 days later. Jmjd3 mRNA levels are shown. Inset: Ikkg immunoblot in untreated and Tat-Cre-treated cells.
(C) The mouse Jmjd3 gene. The structure of the annotated mouse Jmjd3 gene (NM_001017426) is shown (small boxes: noncoding exons). The
sequence of the conserved kB sites is shown (arrows indicate the 50-to-30 orientation). ESC-TSS: TSS in ES cells; MF-TSS: TSS in macrophages.
(D) Anti-p65 ChIP. Immunoprecipitated DNA was amplified by Q-PCR with primers surrounding kB site-containing regions (1, 2, and 3). DNA recov-
eries are expressed as percentage of input (mean ± standard error).
(E) Mapping of the macrophage-specific TSS of Jmjd3. Left: Q-PCR analysis of spliced exon1-exon2 transcripts and internal spliced transcripts.
Right: H3Lys4me3 ChIP. Immunoprecipitated DNA was amplified with primers surrounding the mapped TSS (ESC-TSS) or the region surrounding
the functional kB sites (indicated as MF-TSS in panel B).recruitment to these three regions. In LPS-stimulated cells,
p65/RelA selectively bound to region 2 (Figure 2D), which
lies upstream of the second exon in the annotated Refseq
transcript. Since kB sites are most often located in pro-
moters and close to transcriptional start sites (TSSs), we
analyzed whether the mapped TSS in the Jmjd3 gene is
functional in macrophages. To do so we first analyzed
the presence and inducibility of transcripts in which anno-
tated exon 1 is spliced to exon 2. While these transcripts
were readily detectable in mouse embryonic stem cells
(G.T. andG.N., unpublisheddata), theywereclose toback-
ground levels in macrophages and were not induced by
LPS (Figure 2E, left). As a second criterion for promoter ac-
tivity, wemeasured H3K4me3 levels, as this mark is selec-
tively localized at active TSSs (The ENCODE Consortium,
2007). Only the region preceding the second exon was
associated with robust and constitutive H3K4me3 levels
in macrophages (Figure 2E, right). Therefore, while the
TSS corresponding to the RefSeq transcript is active in
ES cells, inducible transcription of Jmjd3 in macrophages
relies on a promoter located next to the functional kB sites.1086 Cell 130, 1083–1094, September 21, 2007 ª2007 Elsevier InJmjd3 Is a Selective H3K27me3 Demethylase
Phylogenetic clustering of JmjC-domain-containing pro-
teins indicates that Jmjd3 belongs to the Utx/Uty subfam-
ily (Klose et al., 2006). Utx and Uty are broadly expressed
proteins characterized by N-terminal tetratricopeptide
repeats (TPRs) and a C-terminal JmjC domain. In Jmjd3
the only clearly identifiable domain is the C-terminal JmjC
(Figure 3D). The Utx gene is located on the X chromosome
and is one of the few genes that escape X inactivation: it is
likely that Uty expression from the Y chromosome inmales
reflects a mechanism of dosage compensation (Green-
field et al., 1998). Sequence analysis within and outside of
the JmjC domain (Figure 3A) (Klose et al., 2006) indicates
that Utx and Uty are more similar to each other than to
Jmjd3. However, all three proteins contain conserved
iron-binding residues (Figure 3A). The first a-KG-binding
site (red # in Figure 3A) is conserved, and the second one
shows a conservative Lys > Arg substitution in Jmjd3.
Because of these features, Utx, Uty, and Jmjd3 are pre-
dicted to bind Fe(II) and a-KG and to possess enzymatic
activity.c.
Figure 3. Jmjd3 Is a H3K27me3-Specific Demethylase
(A) Alignment of the human and mouse members of the Utx subfamily of JmjC domain proteins. Asterisks (*) indicate the conserved iron-binding
residues and # the cofactor-binding residues. A 22 aa insertion typical of this subfamily is indicated by a red line.
(B) Subcellular localization of Jmjd3. Stimulated Raw264.7 macrophages were fractionated and endogenous Jmjd3 in the nuclear and cytoplasmic
fractions analyzed by western blot. Histone H3 and tubulin western blots are shown as controls of the fractionation procedure.
(C) Effects of HA-Jmjd3 overexpression in HEK293 cells on methylated histone residues. Substrate specificity was analyzed in vivo by double indirect
immunofluorescence with an anti-HA antibody and the indicated anti-methyl histone antibodies. Transfection was carried out in low-efficiency
conditions to obtain a few HA-positive cells in each field.
(D) The C terminus of Jmjd3 is sufficient for H3K27me3 demethylation. HA-tagged WT Jmjd3 (1141–1641) or an iron-binding-deficient mutant were
overexpressed in HEK293 cells. Histonemethylation was evaluated bywestern blot using the indicated antibodies. Transfection efficiency (measured
by GFP transfection of a parallel plate) was 92%–95%.
(E) Recombinant Jmjd3 demethylates H3K27me3 in vitro. Left: Purified His tag-Jmjd3 (1141–1641) expressed in bacteria. Predicted size is 60 kd.
Asterisk indicates a contaminant. Right: in vitro demethylation reaction using histone H3 as substrate. Effects of iron removal from the reaction is
shown.Since some JmjC-domain-containing proteins are cyto-
plasmic, we first checked the subcellular localization of
endogenous Jmjd3 in fractionated extracts from LPS-
stimulated Raw264.7 macrophages. At all the time points
analyzed Jmjd3 was found to be exclusively nuclear
(Figure 3B). We were not able to detect the endogenous
protein by immunostaining. However, low-level expres-
sion of transfected HA-Jmjd3 resulted in an exclusively
nuclear localization and a preferential accumulation in
heterochromatic compartments (Figure S1).
To determine the ability of Jmjd3 to promote site-spe-
cific histone demethylation, we overexpressed HA-tagged
full-length Jmjd3 in HEK293 cells and carried out a double
staining with an anti-HA antibody and modification-spe-
cific antibodies recognizing individual H3 or H4 methyl
lysines. Jmjd3 overexpression selectively and efficiently
abrogated H3K27me3 (Figure 3C). About 75% of HA-
Jmjd3-expressing cells had reduced or undetectable
levels of H3K27me3, and this effect could be reproduced
in other cell types (Figure S2).Cell 1Expression of the C-terminal region of Jmjd3 (aa 1141–
1641, corresponding to the annotated transcript
AK129121), which contains the JmjC domain, was suffi-
cient to downregulate H3K27me3 levels (Figure 3D).
Mutation to Ala of His1388 in the iron-binding center abro-
gated Jmjd3 effects on H3K27me3, thus suggesting the
requirement for iron-mediated catalysis. In spite of its
high-level expression, Jmjd3 1141–1641 did not affect
other methylated residues, thus indicating a remarkable
level of specificity (Figure 3D).
Finally, we tested the ability of recombinant Jmjd3 to
catalyze H3K27me3 demethylation in vitro. Full-length
Jmjd3 expressed in insect cells precipitated during the
purification procedure, possibly due to the unfolding of
very low complexity regions at the N terminus. Instead
we were able to express in bacteria and purify to >85%
purity the C terminus of Jmjd3 (aa 1141–1641) fused to
a polyhistidine tag (Figure 3E). In an in vitro demethylation
reaction using extractive histone H3 as substrate, Jmjd3
(1141–1641) demethylated H3K27me3 (and with lower30, 1083–1094, September 21, 2007 ª2007 Elsevier Inc. 1087
Figure 4. HoxA Genes Are Targets of Jmjd3 in Bone Marrow Cells
(A) Jmjd3 and Utx levels in bone marrow progenitor cells (pro) and in macrophages. Levels of the macrophage-specific marker F4/80 during differ-
entiation are also shown. Mean ± standard error of the mean (SEM) are shown. (B) Downregulation of genes of the late HoxA cluster during differen-
tiation (mean ± standard error).
(C) Anti-Jmjd3 ChIP assay in bone marrow progenitors (p) and differentiated macrophages (mf). Immunoprecipitated DNA was amplified with
promoter-specific primers. In the bottom panel the y axis scale was changed to show the enrichment of Jmjd3 at HoxA11. Nfkbia was used as a
negative control.
(D) Changes in H3K27me3 levels at HoxA7 and HoxA11 during differentiation.efficiency H3K27me2) in an iron-dependent manner
(Figure 3E), thus demonstrating that Jmjd3 is a bona fide
histone H3K27me3 demethylase.
Late HoxA Genes Are Jmjd3 Targets
in Differentiating Bone Marrow Progenitor Cells
Gene-specific reciprocal changes in H3K27me3 and
H3K4me3 levels during differentiation underlie cell- and
tissue-specificgeneexpression.H3K4me3-specificHDMs
contribute to establish histone methylation patterns dur-
ing differentiation (Klose et al., 2007), thus suggesting
that H3K27me3 HDMs may be involved as well. Therefore
we analyzed Jmjd3 behavior during macrophage differen-
tiation.
Jmjd3was highly expressed in differentiating bonemar-
row cells and downregulated in differentiated macro-
phages (Figure 4A). Conversely, Utx was expressed at
constant levels, thus indicating that as observed inmacro-
phages Jmjd3 regulation is dynamic, while Utx behaves
as a housekeeping gene.
The high-level expression of Jmjd3 in differentiating
bone marrow cells stimulated us to search for possible1088 Cell 130, 1083–1094, September 21, 2007 ª2007 Elsevier InJmjd3 targets among Hox genes, which are well-charac-
terized targets of both the mixed lineage leukemia (MLL)
family of H3K4 histone methyltransferases (HMTs) and
the Polycomb system and are dynamically regulated
during differentiation (Sparmann and van Lohuizen,
2006). In U-937 myelomonocytic leukemia cells genes of
the ‘‘late’’ HoxA cluster (HoxA7–13) are kept active by
association with the H3K4 HMT MLL1 (Guenther et al.,
2005; Milne et al., 2005). Consistent with these data,
genes of the late HoxA clusters were active in precursors
and downregulated in macrophages, while HoxA1
showed the opposite behavior (Figure 4B). Both HoxA7,
which in the differentiating population analyzed is the
most active gene in the late HoxA cluster, and HoxA11,
which is the least active one, were immunoprecipitated
by the anti-Jmjd3 antibody in ChIP assays (Figure 4C).
Although occupancy of HoxA7 was comparatively much
more robust, binding of Jmjd3 to HoxA11 was obviously
above the background measured with a control antibody
(Figure 4C, bottom panel). Only background levels of
a control gene (Nfkbia) were detected in the anti-Jmjd3
immunoprecipitates (Figure 4C, bottom panel). Terminalc.
Figure 5. Gene-Specific H3K27me3 Demethylation by Jmjd3 in Macrophages
(A) Diagram showing the procedure used for retroviral infection of bone marrow cells and macrophage generation. Prog: progenitors; Mf: macro-
phages.
(B) Effects of retroviral shRNA on Jmjd3 mRNA during differentiation.
(C) shRNA-mediated Jmjd3 knockdown in LPS-stimulated primary macrophages. Effects of Jmjd3 knockdown on H3K27me3 levels are shown.
Asterisk: nonspecific. Arrow indicates Jmjd3.
(D) Microarray analysis in WT and Jmjd3-depleted macrophages. List of downregulated genes is in Table S2.
(E) Bmp-2 mRNA levels in WT and Jmjd3-depleted macrophages (mean ± SEM).
(F) H3K4me3 at the Bmp-2 gene promoter (mean ± SEM).
(G) H3K27 me3at Bmp-2 in WT and Jmjd3-depleted macrophages were measured by ChIP assay (mean ± SEM).
(H) Anti-Jmjd3 ChIP in WT and Jmjd3-depleted cells (mean ± SEM.).
(I) H3K27 me3 levels at HoxA11 in wt and Jmjd3-depleted cells (mean ± SEM).differentiation was associated with a sharp drop in Jmjd3
occupancy of both HoxA7 and HoxA11, which correlated
with a 3- to 4-fold increase in H3K27me3 levels (Figure 4D)
and gene inactivation.
Jmjd3Controls H3K27me3 Levels at Target Genes
in Activated Macrophages
Wenext investigated the link between Jmjd3 and the poly-
comb system in LPS-activated macrophages using RNA
interference (RNAi). We established an infection protocol
in which retroviruses expressing the relevant short-hairpin
RNA (shRNA) are used to infect bone marrow cells that
proliferate and differentiate in the presence of M-CSF
(Figure 5A). Cells were infected at day 1 and 2 after plating
in M-CSF: a partial (50%–60%) knockdown was already
observed at day 3, while in terminally differentiated mac-
rophages knockdown efficiency was higher than 90% at
the mRNA level (Figure 5B) and the protein was nearly
undetectable (Figure 5C). Knockdown of Jmjd3 did not
cause any obvious impairment of macrophage differentia-
tion, judging from the normal increase of the macrophageCell 1marker F4/80 during differentiation and from the produc-
tion of macrophage-specific cytokines (like IL-12b) in re-
sponse to stimulation (Figure S3). However, since efficient
depletion of Jmjd3 requires time and is not observed in
differentiating precursors at day 3 of our protocol, we can-
not rule out the possibility that macrophage differentiation
requires Jmjd3 expression at early stages and/or that
more subtle effects have been overlooked.
Although an artificial increase in Jmjd3 levels is sufficient
to erase H3K27me3 from transfected cells (Figure 3C),
Jmjd3 induction in LPS-activated macrophages did not
cause any detectable and reproducible reduction in
H3K27me3 (Figure 5C). In a specular manner, Jmjd3 de-
pletion did not provoke any global increase in H3K27me3,
either before or after stimulation with LPS + IFNg (Fig-
ure 5C). Stability of H3K27me3 is not due to a compensa-
tory increase in Ezh2, whose levels remained constant
(Figure S4). The lack of global effects on H3K27me3 in
spite of the strong increase in Jmjd3 expression driven
by LPS is likely due to the existence ofmechanisms target-
ing Jmjd3 to a restricted number of chromatin targets,30, 1083–1094, September 21, 2007 ª2007 Elsevier Inc. 1089
whoseefficiency canbecompromisedonly byoverwhelm-
ing amounts of Jmjd3 in overexpression experiments.
To identify Jmjd3 target genes we carried out microar-
ray analysis in LPS-stimulated WT or Jmjd3-depleted
primary bone marrow-derived macrophages. Only a small
number of inducible transcripts showed reproducible
changes (reduction or increase) in Jmjd3-depleted cells.
To rule out off-target effects caused by the Jmjd3 shRNA,
relevant data were also validated with a second hairpin
depleting Jmjd3 with a similar efficiency (Figure S5).
Data obtained at 4 hr and 8 hr identified a number of
potential Jmjd3 target genes, among which no one was
an obvious polycomb target (Figure S6).
Data obtained at the 24 hr time point showed that apart
from Jmjd3 itself, the most downregulated transcript in
knockdown cells was the one encoding for bone morpho-
genetic protein 2 (Bmp-2) (Figure 5D and Table S2). Since
Bmp-2 is a validated target of PcGproteins (Bracken et al.,
2006), we used it as amodel to investigate the relationship
between PcG and Jmjd3. In response to LPS stimulation
Bmp-2 underwent a rapid low-level activation that was
identical in WT and knockdown cells, while the further 5-
fold increase in Bmp-2 mRNA occurring between 8 and
24 hr was compromised in Jmjd3-depleted cells (Fig-
ure 5E). The promoter of the Bmp-2 gene in macrophages
harbors a bivalent chromatin domain with high levels of
both H3K4me3 and H3K27me3 (Figures 5F and 5G). While
H3K4me3 remained constant throughout the stimulation
(Figure 5F), H3K27me3 was slowly downregulated with a
35%–40% loss at 8 hr poststimulation (Figure 5G), which
followed initial occupancyof thegenebyJmjd3 (Figure5H).
While Jmjd3 depletion increased basal H3K27me3 only
slightly, it completely prevented H3K27me3 downregula-
tion at 8 hr poststimulation (Figure 5G). Increased tran-
scription clearly lags behind the reduction in H3K27me3
levels, which suggests the existence of additional underly-
ing levels of control, consistent with previous observations
(Bracken et al., 2006). Overall, these data indicate that the
failure to increase transcription of Bmp-2 between 8 and
24hr in theabsenceof Jmjd3 isdue to the inability todown-
regulate H3K27me3 levels.
HoxA11, which is a target of Jmjd3 in differentiating
bone marrow cells (Figure 4), in macrophages is an inac-
tive gene with high and constant H3K27me3 levels during
stimulation (Figure 5I). Interestingly, H3K27me3 at this
gene was constitutively 3- to 4-fold higher in Jmjd3-
depleted cells as compared to control cells: we suggest
that the progressive depletion of Jmjd3 during differentia-
tion (Figure 5B) shifts the balance toward a hypermethy-
lated state that is maintained in differentiated macro-
phages.
Association of Jmjd3 with RbBP5-Containing
Complexes
Changes in H3K4me3 and H3K27me3 are coordinately
controlled at genes activated or repressed during differen-
tiation (Boyer et al., 2006; Lee et al., 2006), which suggests
an integration of the enzymatic activities responsible for1090 Cell 130, 1083–1094, September 21, 2007 ª2007 Elsevieplacing and removing the methyl groups at K4 and K27.
Consistent with this idea, purification of a multimolecular
complex associated withMLL2/ALR, a histone H3K4-spe-
cific HMT, resulted in the retrieval of Utx (Issaeva et al.,
2007), which in principle endows this complex with the
whole complement of enzymatic activities required to
activate genes silenced by H3K27me3.
In mammalian cells H3K4 methylation is carried out by
the HMTs of the MLL family (Ruthenburg et al., 2007):
Set1a, Set1b, and the five MLL proteins. All these HMTs
are active only in the context of multimolecular complexes
whose core consists of three obligatory components
(Wdr5, RbBP5, and Ash2L) associated with one of the
MLL proteins and additional partners (Hughes et al.,
2004; Wysocka et al., 2005; Yokoyama et al., 2004).
Wdr5 is required to keep the HMT associated with the
rest of the complex and to bridge it with the H3 tail (Dou
et al., 2006). Because of this essential activity, Wdr5 is
required for global H3K4 methylation and Hox gene acti-
vation (Wysocka et al., 2005).
Since Utx and Jmjd3 are highly homologous, and since
Jmjd3 binds to targets of MLL complexes, like the HoxA
genes (Figure 4), we tested if Jmjd3 is similarly incorpo-
rated in cellular complexes containing Wdr5 and RbBP5.
First we transfected HEK293 cells with Flag-tagged Jmjd3
or Utx and analyzed their incorporation in endogenous
complexes by coimmunoprecipitation (Figure 6A). Anti-
Flag immunoprecipitates were immunoblotted with anti-
bodies against Wdr5, RbBP5, and Ash2L. Utx and Jmjd3
coimmunoprecipitated comparable amounts of all these
proteins, consistentwith the inclusion insimilar complexes.
To determine if LPS stimulation results in the incorpora-
tion of endogenous, newly synthesized Jmjd3 in RbBP5
complexes, we carried out coimmunoprecipitation experi-
ments in LPS-treated Raw264.7 macrophages. An anti-
RbBP5 polyclonal antibody was used because of its high
efficiency in immunoprecipitation (Figure6B).RbBP5coim-
munoprecipitated about 10% of the endogenous Ash2L,
irrespective of LPS stimulation. A comparable percentage
of Jmjd3 was immunoprecipitated selectively from cells
treated with LPS, indicating that newly synthesized Jmjd3
is incorporated in RbBP5-containing complexes.
Data obtained in overexpression experiments indicate
that RbBP5 complexes coimmunoprecipitated by Jmjd3
contain MLL4/Trx2 but not MLL1 (E.P., G.T., and G.N.,
unpublished data), indicating that in fact they may harbor
H3K4 HMT activity. Although the exact molecular compo-
sition of the complexes incorporating Jmjd3 will require
further investigation, these results raise the possibility
that different Utx family members may pair with selected
MLL proteins.
DISCUSSION
Trimethylation of histone H3 at K27 by Ezh2 is the central
biochemical event linking the Polycomb system to gene
silencing and maintenance of the proper spatiotemporal
expressionofgenescontrollingcell fate anddifferentiation.r Inc.
Figure 6. Incorporation of Jmjd3 in RbBP5-Cntaining Coregulator Complexes
(A) HEK293 cells were transfected with a Flag-Jmjd3 or a Flag-Utx expression vector. Anti-Flag immunoprecipitates were immunoblotted with the
indicated antibodies. The lower band in the Jmjd3 lane in the anti-Flag blot is a degradation product.
(B) Association of endogenous Jmjd3with RbBP5-containing complexes. Raw 264.7macrophages were stimulated with LPS for 4 hr or left untreated.
Lysates (in 150 mM NaCl) were immunoprecipitated with an anti-RbBP5 rabbit polyclonal antibody or control rabbit immunoglobulins (mock) and
immunoblotted as indicated. A fraction of the lysate (10% of the input) is shown on the left. H.C.: heavy chains.Since maintenance of cell identity and differentiation
depends on H3K27me3 and Polycomb-enforced gene
silencing, the existence of enzymes that can erase the
methyl mark on which cellular memory relies is counterin-
tuitive at first sight. It is evenmore counterintuitive the idea
that the expression of such an enzyme can be induced by
stimuli as common as bacterial components and inflam-
matory cytokines. In this regard it is important to notice
the different properties of Utx, which is a constitutively
expressed H3K27me3 histone demethylase (HDM), and
Jmjd3, which is endowed with a potent HDM activity but
is expressedmainly in an inducible and cell-type restricted
fashion. Moreover, Utx escapes X inactivation (Greenfield
et al., 1998), and the requirement for a biallelic expression
is suggested by the presence in males of a highly related
gene (Uty) encoded by the Y chromosome. The properties
of the two H3K4me3 HDMs Smcx and Smcy are remark-
ably similar to those of Utx and Uty: they are both encoded
by sex chromosomes, and Smcx escapes X inactivation
(Klose et al., 2006). Overall, it is likely that Utx/Uty (and
Smcx/Smcy) act as ‘‘housekeeping’’ HDMs whose con-
stant availability allows for continuous surveillance over
global and gene-specific H3 Lys 27 (or H3K4) methylation.
Conversely, tissue-specific and inducible expression of
Jmjd3 restricts its field of competence to specific and
well-defined developmental stages or functional states,
thus limiting the intrinsic dangerousness of the increased
availability of a potent H3K27me3 demethylase.Cell 13Considering the risks, what is the advantage of the
potential increase in epigenomic plasticity afforded by
the elevation in Jmjd3 levels? A limited level of plasticity
may allow cells to reprogram their properties according
to environmental cues, which is a well-known event in flies
(Lee et al., 2005; Orlando, 2003). Tissue regeneration that
follows injury requires an efficient reconstitution of the
damaged parts, and in some cases the ability of resident
stem cells to reconstitute the tissue may be exceeded.
When such a deficiency occurs, restoration of tissue
integrity may require the recruitment of circulating cells
whose plasticity enables them to transdifferentiate and
generate a variety of tissue-specific cell types. However,
plasticity of recruited cells may itself represent a risk, as
it may result in the generation of abnormally differentiated
cells and even tumorigenesis. A striking example of the
progression through chronic inflammation > recruitment
of circulating cells > transdifferentiation and tumor devel-
opment, is provided by a mouse model of chronic gastritis
caused by Helicobacter Felis (Houghton et al., 2004), a
relative of the major cause of gastric cancer in humans,
H. Pilori. In this model, chronic inflammation associated
with bacterial infection causes extensive apoptosis of the
gastric epithelium, followed by the invasion of the stom-
ach by circulating bone marrow-derived cells (BMDCs).
BMDCs proliferate in the inflamed stomach and undergo
a transdifferentiation-like event known as metaplasia:
although metaplasia is supposed to be an entirely0, 1083–1094, September 21, 2007 ª2007 Elsevier Inc. 1091
epigenetic event not associated with mutations, it leads to
displasia and eventually to cancer (Houghton et al., 2004).
Macrophages are among the most abundant cells in an
inflamed tissue, and they may help tissue repair also by
transdifferentiation. Although several claims of macro-
phage transdifferentiation in the past could be explained
by cell fusion (Raff, 2003), the case of lymphoendothelial
transdifferentiation in inflamed tissues is supported by
strong experimental evidence. In a mouse model of cor-
neal transplantation (Maruyama et al., 2005)macrophages
infiltrating the transplanted cornea start expressing lym-
phoendothelial markers and the fate-determining tran-
scription factor Prox1, which is essential for lymphatic
vessel development. Later on, macrophage markers are
lost and infiltrating cells retaining only lymphoendothelial
markers generate a new network of lymphatic vessels.
Similarly, neo-lymphoangiogenesis in transplanted and
rejected kidneys in humans depends on recipient-derived
myeloid cells (Kerjaschki et al., 2006). Interestingly, the
Prox1 promoter in macrophages bears both high
H3K4me3 and H3K27me3, and transcription is undetect-
able (F.D.S. and G.N., unpublished data). However, we
have not been able to observe H3K27me3 demethylation
and Prox1 gene reactivation in the conditions used, which
suggests the requirement for additional stimuli present in
inflamed tissues. Lymphoendothelial trans-differentiation
of macrophages during inflammation may help removal
of tissue debris and enhance transport of microbial com-
ponents to lymph nodes for presentation to lymphocytes.
Therefore, it may not represent an accidental event but
a controlled and desirable outcome.
The direct targets of Jmjd3 include late HoxA cluster
genes in differentiating bone marrow cells and Bmp-2 in
activated macrophages. While regulation of Hox genes
tentatively identifies Jmjd3 as a component of the MLL
system (an assumption supported by the inclusion of
Jmjd3 in MLL complexes), regulation of Bmp-2 provides
interesting mechanistic and biological clues. In macro-
phages the Bmp-2 gene promoter contains a bivalent
chromatin domain with high H3K4me3 and H3K27me3
levels. It has been proposed that in ES cells genes in this
configuration are silenced but poised for rapid activation
when differentiation is triggered (Bernstein et al., 2006),
which implies a functional dominance of the inhibitory
mark (H3K27me3) over the active one (H3K4me3). In differ-
entiated cells bivalent domains may have a more complex
function in fine-tuning gene expression, as suggested by a
genome-wide analysis in T lymphocytes (Roh et al., 2006):
genes bearing H3K4me3 could be clustered according to
their H3K27me3 levels in genes with low transcriptional
activity (high H3K27me3), genes with high transcriptional
activity (low H3K27me3), and finally genes with intermedi-
ate levels of H3K27me3 and intermediate degrees of activ-
ity. Therefore, not only the presence or absence of the
H3K27me3 mark is relevant, but also its abundance rela-
tive to H3K4me3. Our data on Bmp-2 are consistent with
this model. Bmp-2 gene transcription is rapidly activated
in both WT and Jmjd3-depleted cells, although initial acti-1092 Cell 130, 1083–1094, September 21, 2007 ª2007 Elsevievation is rather low. Between 8 and 24 hr poststimulation
a sharp increase in Bmp-2 mRNA is observed, but only
in WT cells, in which H3K27me3 levels at the Bmp-2 pro-
moter are reduced in a Jmjd3-dependent manner.
The observation that newly synthesized Jmjd3 is incor-
porated in RbBP5-containing complexes suggests a
possible model for the control of histone marks at genes
bearing a bivalent domain. An attractive possibility is
that a constitutively bound MLL complex devoid of a
H3K27me3 HDM component is exchanged for a Jmjd3-
containing MLL complex generated after LPS stimulation,
thus allowing H3K27me3 demethylation while keeping
constant the levels of H3K4me3.
Bmp-2 is a morphogen essential for embryonic devel-
opment. It controls cell growth and promotes tumorigene-
sis, and it induces the differentiation of mesenchymal cells
into osteoblasts (Gazzerro andCanalis, 2006). Bmp-2 pro-
duction by activated macrophages participates in healing
of bone fractures but also underlies heterotopic bone
formation in inflamed joints (Fujimori et al., 1992) and other
tissues (Zhang et al., 2003). Therefore, control of macro-
phage production of Bmp-2 by Jmjd3 is an indirect mech-
anism by which H3K27me3 demethylation in activated
macrophages can impinge on the physiology of inflamed
tissues.
In conclusion, our data support the conceptually chal-
lenging idea that a histone mark involved in the control
of differentiation and in the maintenance of cellular mem-
ory can be erased by a rapidly inducible enzyme whose
expression is regulated by common environmental stimuli.
EXPERIMENTAL PROCEDURES
Antibodies and Reagents
The anti-Jmjd3 antibody was raised in rabbits and affinity purified by
Abgent (San Diego, CA, USA). Anti-p65 (C20) was from Santa Cruz
Biotechnology, and anti-IkBa from Imgenex. Antibodies against
methylated histones were from Abcam (ab8580 H3K4me3; ab7766
H3K4me2; ab8895 H3K4me1; ab9050 H3K36me3; ab3594
H3K79me2) or Upstate Biotechnology (#07-449 H3K27me3; #07-452
H3K27me2; #07-448 H3K27me1; #07-442 H3K9me3; #07-441
H3K9me2; #07-450 H3K9me1; #07-354 H4K20me3; #07-463
H4K20me2; #07-367 H4K20me1). The anti-Wdr5 antibody is a gift
from B. Amati. The anti-RbBP5 antibody is from Bethyl laboratories,
while anti-Ash2L is from Abcam (Ab28426). LPS from E.Coli serotype
055:B5 (Sigma), was used at 100 ng/ml while gIFN (R&D) was used
at 10 UI/ml.
Quantitative RT-PCR
RNA was extracted from macrophages using Trizol (Invitrogen) and
reverse transcribed with random hexamers. The sequences of the
primers used are in Table S1.
Plasmids
The full-length Jmjd3 cDNA (clone IMAGp4002F091D) was subcloned
into the pRcb-3xHA vector. The 1141–1641 C-terminal domain was
amplified by PCR using the primers 50 CTTCATATGCGT GCCAGCAA
GAATGCCAAG 30 and 50 ATTGCGGCCGCTCATCGAGACGTGCT
GGCGGGAGCCAG 30, and subcloned into pRcb-3xHA. The 1141–
1641 His1388 > Ala mutant was generated by mutagenic PCR using
primers D3M1S (50 AGCCGAACGCCAGGCGCCCAAGAGAATAACAAr Inc.
TTTC 30) and D3M1 AS (50 GAAATTGTTATTCTGTTGGGCGCCTGGC
GTTCGGCT 30).
In Vitro Histone Demethylation
TheC terminus ofmouse Jmjd3 (aa 1141–1641) was cloned in pETM14
in frame with a 6xHis tag, expressed in bacteria and purified from the
soluble fraction. Reactions containing between 2.5 and 10 mg of Jmjd3
and 2.5 mg of calf thymus histone H3 were incubated for 4 hr in a
reaction buffer containing 50 mM Tris (pH 8.0), 10% glycerol, 1 mM
a-ketoglutarate, 80 mM FeSO4, and 2 mM ascorbic acid.
Adenoviral Infection
The adenovirus expressing HA-tagged IkBa-SR (Jobin et al., 1998)
was obtained from the University of North Carolina core vector facility
and used at a MOI of 50:1.
Primary Bone Marrow-Derived Macrophages
Bone marrow cells were isolated from female Fvb mice (to eliminate
the variable of a different dosage of Utx). Onemillion bonemarrow cells
were plated in 10 cm plates in 5 ml of BM-medium (DMEM supple-
mented with 20% low-endotoxin fetal bovine serum, 30% L929-cell
conditioned medium, 1% L-glutamine, 1% Pen/Strep, 0.5% Na Pyru-
vate, 0.1% b-mercaptoethanol) and fed with 2.5 ml of fresh medium
every 2 days.
Retroviral Constructs and Production of Retroviruses
All shRNA constructs were prepared in the MSCV-based pLMP retro-
viral vector (Dickins et al., 2005). The hairpins used in the study are
shown in Figure S5. Supernatants from transfected Phoenix-ECO
packaging cells were collected at 48 and 60 hr post transfection and
immediately used for infections.
Retroviral Transduction of Bone Marrow-Derived
Macrophages
On day 0, bone marrow cells were isolated and 33 106 cells/well were
seeded on 6-well plates in BM medium. Spin infection was performed
for 2 consecutive days (2 infections per day). On days 1–2, the cells
were first spun at 2500 rpm for 5 min, the medium was removed, and
the retroviral supernatants were added with 8 mg/ml polybrene and
10 ml/ml of 1M HEPES pH 7.5. Spin infections continued for 1.5 hr at
2500 rpm and 30C, followed by gentle removal of the virus-containing
medium and addition of fresh BM medium. Puromycin selection
(3 mg/ml) started on day 3. Assays were carried out at days 7–8.
Chromatin Immunoprecipitation (ChIP)
ChIP assays were carried out as previously described (Bosisio et al.,
2006). Sequences of the ChIP primers used and a detailed protocol
are available upon request.
Microarray Analysis
Bone marrows from Fvb mice were infected with the control LMP vec-
tor or with the vector expressing the Jmjd3-specific shRNA (shRNA#6).
After differentiation into macrophages, cells were stimulated with
100 ng/mL LPS + 10 U/mL IFN-g and RNA was purified using an
RNeasy-QIAGENMaxi kit. Quality analysis of total RNA, cRNA synthe-
sis, hybridization, and data extraction were performed at the Microar-
ray Core Facility of the IFOM-IEO campus. MOE_430 2.0 arrays (Affy-
metrix) were used for gene expression screening. Results were
captured and analyzed using GeneChip analysis software (Affymetrix,
Inc.).
Supplemental Data
Supplemental Data include six figures and two tables and can be found
with this article online at http://www.cell.com/cgi/content/full/130/6/
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